XU6-31289-37726
2 vaccinations
7 coded responses
16 check-ins
7 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 109 / NY
- Registered
- 2021-04-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Dose 1 — Pfizer-BioNTech
-
2021-04-27
Registered in v-safe
-
2021-04-27
Survey response — 14 day, dose 1MedDRA: Abdominal pain, Diarrhoea, Medical counselling — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-27
Report sent to call center — 14 day, dose 1Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-30
Dose 2 — Pfizer-BioNTech
-
2021-04-30
Health check-in — 0 day, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-01
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-03
Survey response — days 1–6 daily, dose 2MedDRA: Eye pain, Lacrimation increased — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-05-04
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-05-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea, Diarrhea, Abdominal painAdult check-in
- 2021-05-06
- 2021-05-07
-
2021-05-14
Survey response — 14 day, dose 2MedDRA: Pollakiuria — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-05-21
Survey response — 21 day, dose 2MedDRA: Injection site pain, Pain in extremity — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-05-30
- 2021-06-04
-
2021-06-13
Survey response — 42 day, dose 2MedDRA: Chromaturia, Dysmenorrhoea, Heavy menstrual bleeding, Spider vein — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-06-13
Report sent to call center — 42 day, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-15
-
2021-10-31
Survey response — 6 month, dose 2MedDRA: Arthralgia, Asthenia, Body temperature fluctuation, Diarrhoea, Fatigue, Headache, Hypersensitivity, Paraesthesia, Peripheral swelling, Syncope — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11 · check-in answers available
-
2021-10-31
Report sent to call center — 6 month, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2021-11-03
- 2022-05-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Pfizer-BioNTech | |
| 2 | 2021-04-30 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-27 | Unsuccessful | |
| 2021-06-13 | Unsuccessful | |
| 2021-10-31 | Unsuccessful |
Free text
Release 8
Symptoms: Abdominal pain/diarrhea (past several days)
Healthcare visit (other): Phone consults with GI and Endocrinology doctors in recent days
Systemic reaction (other): Eye pain and watery eyes
Systemic reaction (other): Dizziness
Symptoms: Frequent urination
Symptoms: Arm pain (not at injection site) and some at injection site
Release 9
Symptoms: Severe menstrual cramping and heavier than normal menstrual cycle bleeding; spider veins on both inner thighs; neon yellow urine (now cleared)
Release 10
Symptoms: Diarrhea, headaches and head pains, joint pain, weakness, fainting, swelling of feet, tingling, temperature irregularities, fatigue, new allergic reactions, etc.
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | ✓ | ✓ | ✓ |
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Asthenia | · | · | ✓ |
| SD | Body temperature fluctuation | · | · | ✓ |
| SD | Chromaturia | ✓ | ✓ | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Dysmenorrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Pain in extremity | ✓ | ✓ | ✓ |
| SD | Paraesthesia | · | · | ✓ |
| SD | Peripheral swelling | · | · | ✓ |
| SD | Pollakiuria | ✓ | ✓ | ✓ |
| SD | Spider vein | ✓ | ✓ | ✓ |
| SD | Syncope | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Eye pain | ✓ | ✓ | ✓ |
| SRO | Lacrimation increased | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release